ArticleRheumatology and therapy2026

Persistence Among Biologic/JAKi-Naive Medicare Beneficiaries with RA Initiating Synthetic DMARDs.

Taylor T Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.